Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Arius' ARH-460-16-2 antibody to be studied for IBD

March 31, 2005

XenoPort advances XP-19986 into phase I trials

March 31, 2005

Protein Design Labs plots Nuvion development pathway

March 30, 2005

U.K. clearance for phase III study of COLAL-PRED for acute ulcerative colitis

March 29, 2005

Roche studies Pegasys and Copegus to treat HCV in liver transplant patients

March 24, 2005

New data presented on the PK profile of alvimopan and DA-6034 at the ASCPT

March 22, 2005

BioLineRx inlicenses BL-1060 for fatty liver disease

March 21, 2005

MNTX shows efficacy in the treatment of opioid-induced constipation

March 17, 2005

ViroPharma and Wyeth discontinue development of HCV-086

March 17, 2005

Janssen describes new treatments for gastrointestinal disorders in recent patents

March 15, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...